Boehringer Ingelheim Investigational Site

Darlinghurst, New South Wales

0 studies enrolling now · 2 studies all time

What they study most

HIV Infections

Studies at this site

• Dual Boosted - Protease Inhibitor (PI) Pharmacokinetics (PK) Trial (Tipranavir / Ritonavir) in Highly Treatment-experienced HIV-1 Infected Patients — Completed
• 3 TPV/RTV Doses in Multiple ARV Experienced Patients - Tipranavir Dose Defining Study — Completed